Comments
Loading...

Bio-Techne

TECHNASDAQ
$77.92
-0.36-0.47%
Last update: 11:14 AM
15 minutes delayed
Consensus Rating1
Outperform
Highest Price Target1
$465.00
Lowest Price Target1
$65.00
Consensus Price Target1
$116.25

want to know what
the Bulls & Bears Say?

Bio-Techne (NASDAQ:TECH) Stock, Analyst Ratings, Price Targets, Forecasts

Bio-Techne Corp has a consensus price target of $116.25 based on the ratings of 13 analysts. The high is $465 issued by Credit Suisse on August 25, 2022. The low is $65 issued by Stifel on February 2, 2024. The 3 most-recent analyst ratings were released by Citigroup, Benchmark, and Baird on May 22, 2024, May 2, 2024, and May 2, 2024, respectively. With an average price target of $87 between Citigroup, Benchmark, and Baird, there's an implied 11.85% upside for Bio-Techne Corp from these most-recent analyst ratings.

Analyst Trends and Forecast
1
Feb
0
0
0
0
Apr
1
1
May
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.4
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Citigroup
Benchmark
Baird
Deutsche Bank
Stifel

1calculated from analyst ratings

Analyst Ratings for Bio-Techne

Buy NowGet Alert
05/22/2024Buy Now9.28%Citigroup
Patrick Donnelly
→ $85DowngradeBuy → NeutralGet Alert
05/02/2024Buy Now22.14%Benchmark
Robert Wasserman
→ $95ReiteratesBuy → BuyGet Alert
05/02/2024Buy Now4.14%Baird
Catherine Schulte
$73 → $81MaintainsOutperformGet Alert
04/18/2024Buy Now5.43%Deutsche Bank
Justin Bowers
$85 → $82MaintainsBuyGet Alert
02/02/2024Buy Now-16.43%Stifel
Daniel Arias
→ $65DowngradeBuy → HoldGet Alert
02/02/2024Buy Now11.85%Stephens & Co.
Jacob Johnson
$92 → $87MaintainsOverweightGet Alert
02/02/2024Buy Now-3.57%RBC Capital
Conor McNamara
$85 → $75MaintainsSector PerformGet Alert
12/07/2023Buy Now2.85%UBS
Dan Leonard
→ $80Initiates → BuyGet Alert
11/02/2023Buy Now-16.43%Stifel
Daniel Arias
$104 → $65MaintainsBuyGet Alert
11/01/2023Buy Now2.85%Citigroup
Patrick Donnelly
$100 → $80MaintainsBuyGet Alert
11/01/2023Buy Now6.71%RBC Capital
Conor McNamara
$85 → $83MaintainsSector PerformGet Alert
11/01/2023Buy Now2.85%Keybanc
Paul Knight
$115 → $80MaintainsOverweightGet Alert
09/12/2023Buy Now10.57%RBC Capital
Conor McNamara
→ $86ReiteratesSector Perform → Sector PerformGet Alert
08/28/2023Buy NowWilliam Blair
Matt Larew
Initiates → OutperformGet Alert
08/18/2023Buy Now54.28%Benchmark
Robert Wasserman
→ $120ReiteratesBuy → BuyGet Alert
08/09/2023Buy Now28.57%Stephens & Co.
Jacob Johnson
→ $100ReiteratesOverweight → OverweightGet Alert
05/04/2023Buy Now15.71%RBC Capital
Conor McNamara
$89 → $90MaintainsSector PerformGet Alert
05/04/2023Buy Now28.57%Stephens & Co.
Jacob Johnson
→ $100Reiterates → OverweightGet Alert
05/04/2023Buy Now28.57%Baird
Catherine Schulte
$99 → $100MaintainsOutperformGet Alert
02/06/2023Buy Now13.14%RBC Capital
Conor McNamara
$89 → $88MaintainsSector PerformGet Alert
02/03/2023Buy Now54.28%Benchmark
Robert Wasserman
→ $120MaintainsBuyGet Alert
02/03/2023Buy Now41.42%SVB Leerink
Puneet Souda
$125 → $110MaintainsOutperformGet Alert
02/03/2023Buy Now47.85%Keybanc
Paul Knight
$125 → $115MaintainsOverweightGet Alert
01/10/2023Buy Now15.71%Wells Fargo
Timothy Daley
→ $90UpgradeUnderweight → Equal-WeightGet Alert
12/14/2022Buy Now28.57%Deutsche Bank
Justin Bowers
→ $100Initiates → BuyGet Alert
12/12/2022Buy Now28.57%Citigroup
Patrick Donnelly
$81.25 → $100UpgradeNeutral → BuyGet Alert
12/07/2022Buy Now14.43%RBC Capital
Conor McNamara
→ $89Initiates → Sector PerformGet Alert
12/05/2022Buy Now35%Stephens & Co.
Jacob Johnson
$420 → $105MaintainsOverweightGet Alert
11/02/2022Buy Now542.84%SVB Leerink
Puneet Souda
$137.5 → $125MaintainsOutperformGet Alert
08/25/2022Buy Now497.84%Credit Suisse
Dan Leonard
→ $116.25Initiates → OutperformGet Alert
08/16/2022Buy Now362.84%Wells Fargo
Timothy Daley
$92.5 → $90MaintainsUnderweightGet Alert
08/05/2022Buy Now517.13%Stephens & Co.
Jacob Johnson
$125 → $120MaintainsOverweightGet Alert
05/05/2022Buy Now542.84%Keybanc
Paul Knight
$150 → $125MaintainsOverweightGet Alert
04/25/2022Buy Now375.7%Wells Fargo
Timothy Daley
$100 → $92.5DowngradeEqual-Weight → UnderweightGet Alert
02/02/2022Buy Now639.26%SVB Leerink
Puneet Souda
$132.5 → $143.75MaintainsOutperformGet Alert
09/15/2021Buy Now671.41%Keybanc
Paul Knight
UpgradeSector Weight → OverweightGet Alert

FAQ

Q

What is the target price for Bio-Techne (TECH) stock?

A

The latest price target for Bio-Techne (NASDAQ:TECH) was reported by Citigroup on May 22, 2024. The analyst firm set a price target for $85.00 expecting TECH to rise to within 12 months (a possible 9.08% upside). 16 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Bio-Techne (TECH)?

A

The latest analyst rating for Bio-Techne (NASDAQ:TECH) was provided by Citigroup, and Bio-Techne downgraded their neutral rating.

Q

When was the last upgrade for Bio-Techne (TECH)?

A

The last upgrade for Bio-Techne Corp happened on January 10, 2023 when Wells Fargo raised their price target to $90. Wells Fargo previously had an underweight for Bio-Techne Corp.

Q

When was the last downgrade for Bio-Techne (TECH)?

A

The last downgrade for Bio-Techne Corp happened on May 22, 2024 when Citigroup changed their price target from N/A to $85 for Bio-Techne Corp.

Q

When is the next analyst rating going to be posted or updated for Bio-Techne (TECH)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Bio-Techne, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Bio-Techne was filed on May 22, 2024 so you should expect the next rating to be made available sometime around May 22, 2025.

Q

Is the Analyst Rating Bio-Techne (TECH) correct?

A

While ratings are subjective and will change, the latest Bio-Techne (TECH) rating was a downgraded with a price target of $0.00 to $85.00. The current price Bio-Techne (TECH) is trading at is $77.93, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch